Intense esophageal FDG activity caused by candida infection obscured the concurrent primary esophageal cancer on PET imaging

Clinical Nuclear Medicine

Volumn 30, Issue 10, 2005, Pages 695-697

  Shrikanthan, Sankaran ^a   Aydin, Aysel ^a   Dhurairaj, Thiruvenkatasamy ^a   Alavi, Abass ^a   Zhuang, Hongming ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANDIDIASIS; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ESOPHAGITIS; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY;

CANDIDIASIS; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; FALSE NEGATIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 25444501534     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000178244.55482.2a     Document Type: Article

References (13)

1. Athey PA, Goldstein HM, Dodd GD. Radiologic spectrum of opportunistic infections of the upper gastrointestinal tract. AJR Am J Roentgenol. 1977;129:419-424.
2. Levine MS, Macones AJ Jr, Laufer I. Candida esophagitis: accuracy of radiographic diagnosis. Radiology. 1985;154:581-587.
3. Redah D, Konutse AY, Agbo K, et al. Is endoscopic diagnosis of Candida albicans esophagitis reliable? Correlations with pathology and mycology. Gastroenterol Clin Biol. 2001;25:161-163.
4. Meltzer CC, Luketich JD, Friedman D, et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer: comparison with computed tomography. Clin Nucl Med. 2000;25:882-887.
5. Kole AC, Plukker JT, Nieweg OE, et al. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer. 1998;78:521-527.
6. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202-3210.
7. Fukunaga T, Okazumi S, Koide Y, et al. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med. 1998;39:1002-1007.
8. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
9. Bhargava P, Zhuang H, Kumar R, et al. Iatrogenic artifacts on wholebody F-18 FDG PET imaging. Clin Nucl Med. 2004;29:429-439.
10. Bhargava P, Reich P, Alavi A, et al. Radiation-induced esophagitis on FDG PET imaging. Clin Nucl Med. 2003;28:849-850.
11. Brink I, Hentschel M, Bley TA, et al. Effects of neoadjuvant radiochemotherapy on F-18-FDG-PET in esophageal carcinoma. EJSO. 2004;30:544-550.
12. Neto C, Zhuang H, Ghesani N, et al. Detection of Barren's esophagus superimposed by esophageal cancer by FDG positron emission tomography. Clin Nucl Med. 2001;26:1060-1060.
13. Bakheet SM, Amin T, Alia AG, et al. F-18FDG uptake in benign esophageal disease. Clin Nucl Med. 1999;24:995-997.